Discovery and Optimization of 1-(4-chloro-3-(trifluoromethyl)- phenyl)-3-(2-(amino)pyridin-3-yl)ureas as Novel KDR Kinase Inhibitors

By  

Medicinal Chemistry, Vol. 12, Iss. 4, 2016-06 ,pp. : 328-337

Bentham Science Publishers

Access to resources Recommend Favorite

Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid

By Slok F.   Ebert B.   Lang Y.   Krogsgaard-Larsen P.   Lenz S.   Madsen U.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 4, 1997-01 ,pp. : 329-338

Elsevier

Access to resources Recommend Favorite

Small Molecule Inhibitors of KDR (VEGFR-2) Kinase: An Overview of Structure Activity Relationships

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 973-1000

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. : 647-663

Informa Healthcare

Access to resources Recommend Favorite

5-Amino-2-carbonylthiophene derivatives for use as p38 MAPK inhibitors in the treatment of inflammatory diseases

By Boehm Jeffrey  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1471-1476

Informa Healthcare

Access to resources Recommend Favorite